{"id":298309,"date":"2026-10-09T12:39:48","date_gmt":"2026-10-09T07:09:48","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=298309"},"modified":"2026-10-09T12:39:48","modified_gmt":"2026-10-09T07:09:48","slug":"bliss-gvs-pharma-share-price-prediction-2027","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/bliss-gvs-pharma-share-price-prediction-2027\/","title":{"rendered":"Bliss GVS Pharma Share Price Prediction 2027: Scenario Targets, Valuation and Technical Outlook"},"content":{"rendered":"

CMP Rs 657.00 (9 Oct 2026). 52W range Rs 118.00 to Rs 739.90. PE 50.36. 2027 base Rs 788, bull Rs 821.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Bliss GVS Pharma share price prediction 2027 centres on a conservative case of Rs 756, a base case of Rs 788 and a bull case of Rs 821, against a current price of Rs 657.00. These targets scale today’s price by reported EPS growth at a constant PE multiple, so they rest on earnings the company has already delivered, not on broker forecasts. The base case implies 19.9% upside from today’s price. The daily technical setup reads mildly bullish.<\/p>\n<\/p><\/div>\n

The Bliss GVS Pharma share price forecast comes down to earnings growth and the multiple investors pay for it, and the reported numbers give a measured answer. The stock trades at Rs 657.00 on NSE as of 9 October 2026, 11.2% below its 52-week high of Rs 739.90, after the company reported net profit of Rs 134.73 crore for FY26.<\/p>\n

This Bliss GVS Pharma stock forecast 2027 builds conservative, base and bull scenarios from exchange-reported financials, shareholding data and daily price indicators, with every assumption shown.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n